Header Logo

Connection

William Dooley to Humans

This is a "connection" page, showing publications William Dooley has written about Humans.
Connection Strength

0.548
  1. Who wants a blind breast surgeon? Ann Surg Oncol. 2011 Dec; 18 Suppl 3:S337-8.
    View in: PubMed
    Score: 0.022
  2. Do the CMS proposed breast cancer quality measures actually predict improved outcomes? Am J Surg. 2011 Dec; 202(6):787-95; discussion 795.
    View in: PubMed
    Score: 0.022
  3. Mechanisms of improved outcomes for breast cancer between surgical oncologists and general surgeons. Ann Surg Oncol. 2011 Nov; 18(12):3248-51.
    View in: PubMed
    Score: 0.021
  4. Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer. World J Surg Oncol. 2011 Mar 07; 9:30.
    View in: PubMed
    Score: 0.021
  5. Clinical series of oncoplastic mastopexy to optimize cosmesis of large-volume resections for breast conservation. Ann Surg Oncol. 2010 Dec; 17(12):3247-51.
    View in: PubMed
    Score: 0.020
  6. Focused microwave thermotherapy for preoperative treatment of invasive breast cancer: a review of clinical studies. Ann Surg Oncol. 2010 Apr; 17(4):1076-93.
    View in: PubMed
    Score: 0.019
  7. Breast ductoscopy and the evolution of the intra-ductal approach to breast cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S90-4.
    View in: PubMed
    Score: 0.019
  8. Ductoscopy--increasing clinical utility. Breast J. 2009 Jul-Aug; 15(4):327-8.
    View in: PubMed
    Score: 0.019
  9. Reducing surgical morbidity by pre-emptive management. J Surg Res. 2009 Dec; 157(2):154.
    View in: PubMed
    Score: 0.018
  10. The intraductal approach to breast cancer. Ann Surg Oncol. 2008 Dec; 15(12):3331-2.
    View in: PubMed
    Score: 0.017
  11. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy. Am J Clin Oncol. 2007 Oct; 30(5):466-72.
    View in: PubMed
    Score: 0.017
  12. A surgical indication in incurable breast cancer. Ann Surg Oncol. 2006 Jun; 13(6):759-60.
    View in: PubMed
    Score: 0.015
  13. Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer. Am J Surg. 2005 Dec; 190(6):918-22.
    View in: PubMed
    Score: 0.015
  14. The future prospect: ductoscopy-directed brushing and biopsy. Clin Lab Med. 2005 Dec; 25(4):845-50, ix.
    View in: PubMed
    Score: 0.015
  15. Understanding the mechanisms creating false positive lumpectomy margins. Am J Surg. 2005 Oct; 190(4):606-8.
    View in: PubMed
    Score: 0.014
  16. Ductal lavage: risk stratification versus cancer detection. Ann Surg Oncol. 2005 Sep; 12(9):681-2.
    View in: PubMed
    Score: 0.014
  17. Nonsurgical ablation of primary breast cancer. Surg Oncol Clin N Am. 2005 Jan; 14(1):33-44.
    View in: PubMed
    Score: 0.014
  18. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
    View in: PubMed
    Score: 0.014
  19. Office-based breast ductoscopy for diagnosis. Am J Surg. 2004 Oct; 188(4):415-8.
    View in: PubMed
    Score: 0.014
  20. Ductoscopy: defining its role in the management of breast cancer. Breast J. 2004 Jul-Aug; 10(4):271-2.
    View in: PubMed
    Score: 0.013
  21. Breast cancer-have we been chasing the wrong target? J Surg Oncol. 2003 Jun; 83(2):57-60.
    View in: PubMed
    Score: 0.012
  22. Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis. Curr Oncol Rep. 2003 Jan; 5(1):63-5.
    View in: PubMed
    Score: 0.012
  23. Routine operative breast endoscopy during lumpectomy. Ann Surg Oncol. 2003 Jan-Feb; 10(1):38-42.
    View in: PubMed
    Score: 0.012
  24. Ambulatory mastectomy. Am J Surg. 2002 Dec; 184(6):545-8; discussion 548-9.
    View in: PubMed
    Score: 0.012
  25. Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol. 2002 Nov; 9(9):920-3.
    View in: PubMed
    Score: 0.012
  26. The future of breast cancer screening and treatment. J Okla State Med Assoc. 2002 Oct; 95(10):635-8.
    View in: PubMed
    Score: 0.012
  27. Breast enhanced scintigraphy testing distinguishes between normal, inflammatory breast changes, and breast cancer: a prospective analysis and comparison with mammography. Integr Cancer Ther. 2002 Sep; 1(3):238-45.
    View in: PubMed
    Score: 0.012
  28. Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature. JCO Precis Oncol. 2022 04; 6:e2100463.
    View in: PubMed
    Score: 0.011
  29. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001 Nov 07; 93(21):1624-32.
    View in: PubMed
    Score: 0.011
  30. Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. PLoS One. 2021; 16(4):e0250726.
    View in: PubMed
    Score: 0.011
  31. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma. Ann Surg Oncol. 2021 Oct; 28(11):5895-5905.
    View in: PubMed
    Score: 0.011
  32. ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter? Ann Surg Oncol. 2021 10; 28(11):5906.
    View in: PubMed
    Score: 0.011
  33. A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer. Breast J. 2021 03; 27(3):231-236.
    View in: PubMed
    Score: 0.010
  34. Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer. Cancer Prev Res (Phila). 2020 07; 13(7):623-634.
    View in: PubMed
    Score: 0.010
  35. Letter to the Editor: A response to Hruska's case study on molecular breast imaging and the need for true tissue quantification. Breast Cancer Res. 2019 01 29; 21(1):15.
    View in: PubMed
    Score: 0.009
  36. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. 2016 09 08; 18(1):90.
    View in: PubMed
    Score: 0.008
  37. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015 Jul 16; 14:133.
    View in: PubMed
    Score: 0.007
  38. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. Mol Ther. 2015 Jun; 23(6):1044-1054.
    View in: PubMed
    Score: 0.007
  39. An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.
    View in: PubMed
    Score: 0.005
  40. Activity of combination chemotherapy, docetaxel and epirubicin as neoadjuvant therapy for women with breast cancer. Anticancer Res. 2006 Nov-Dec; 26(6C):4911-6.
    View in: PubMed
    Score: 0.004
  41. Focused microwave phased array thermotherapy for ablation of early-stage breast cancer: results of thermal dose escalation. Ann Surg Oncol. 2004 Feb; 11(2):139-46.
    View in: PubMed
    Score: 0.003
  42. Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer. 2002 Jan 15; 94(2):292-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.